FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014735311> ?p ?o ?g. }

• W3014735311 endingPage "9496" @default.
• W3014735311 startingPage "9490" @default.
• W3014735311 abstract "Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). In this study, 10 severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL of convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents. The primary endpoint was the safety of CP transfusion. The second endpoints were the improvement of clinical symptoms and laboratory parameters within 3 d after CP transfusion. The median time from onset of illness to CP transfusion was 16.5 d. After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640). The clinical symptoms were significantly improved along with increase of oxyhemoglobin saturation within 3 d. Several parameters tended to improve as compared to pretransfusion, including increased lymphocyte counts (0.65 × 10 9 /L vs. 0.76 × 10 9 /L) and decreased C-reactive protein (55.98 mg/L vs. 18.13 mg/L). Radiological examinations showed varying degrees of absorption of lung lesions within 7 d. The viral load was undetectable after transfusion in seven patients who had previous viremia. No severe adverse effects were observed. This study showed CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases. The optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials." @default.
• W3014735311 created "2020-04-10" @default.
• W3014735311 creator A5008957966 @default.
• W3014735311 creator A5015137228 @default.
• W3014735311 creator A5018569451 @default.
• W3014735311 creator A5020780416 @default.
• W3014735311 creator A5023494462 @default.
• W3014735311 creator A5024175182 @default.
• W3014735311 creator A5025570473 @default.
• W3014735311 creator A5027296655 @default.
• W3014735311 creator A5027475930 @default.
• W3014735311 creator A5027596703 @default.
• W3014735311 creator A5030590159 @default.
• W3014735311 creator A5031077858 @default.
• W3014735311 creator A5033632697 @default.
• W3014735311 creator A5036858909 @default.
• W3014735311 creator A5037989560 @default.
• W3014735311 creator A5038578978 @default.
• W3014735311 creator A5040989330 @default.
• W3014735311 creator A5043171865 @default.
• W3014735311 creator A5043352845 @default.
• W3014735311 creator A5043696990 @default.
• W3014735311 creator A5044277116 @default.
• W3014735311 creator A5044676710 @default.
• W3014735311 creator A5045489948 @default.
• W3014735311 creator A5045534627 @default.
• W3014735311 creator A5048672759 @default.
• W3014735311 creator A5049496067 @default.
• W3014735311 creator A5050544804 @default.
• W3014735311 creator A5051892747 @default.
• W3014735311 creator A5052732719 @default.
• W3014735311 creator A5052948328 @default.
• W3014735311 creator A5056188852 @default.
• W3014735311 creator A5058374925 @default.
• W3014735311 creator A5058380236 @default.
• W3014735311 creator A5060002817 @default.
• W3014735311 creator A5064304246 @default.
• W3014735311 creator A5066425126 @default.
• W3014735311 creator A5066802631 @default.
• W3014735311 creator A5067770963 @default.
• W3014735311 creator A5071391600 @default.
• W3014735311 creator A5073437281 @default.
• W3014735311 creator A5074481938 @default.
• W3014735311 creator A5075975467 @default.
• W3014735311 creator A5078833021 @default.
• W3014735311 creator A5079237097 @default.
• W3014735311 creator A5082424766 @default.
• W3014735311 creator A5084375293 @default.
• W3014735311 creator A5088009780 @default.
• W3014735311 creator A5091521766 @default.
• W3014735311 date "2020-04-06" @default.
• W3014735311 modified "2023-10-16" @default.
• W3014735311 title "Effectiveness of convalescent plasma therapy in severe COVID-19 patients" @default.
• W3014735311 cites W1020548474 @default.
• W3014735311 cites W2028352585 @default.
• W3014735311 cites W2057439500 @default.
• W3014735311 cites W2085978024 @default.
• W3014735311 cites W2095574796 @default.
• W3014735311 cites W2096238447 @default.
• W3014735311 cites W2135926866 @default.
• W3014735311 cites W2148822770 @default.
• W3014735311 cites W2158607167 @default.
• W3014735311 cites W2164310764 @default.
• W3014735311 cites W2169659972 @default.
• W3014735311 cites W2225294925 @default.
• W3014735311 cites W2411743997 @default.
• W3014735311 cites W2412511529 @default.
• W3014735311 cites W2460100043 @default.
• W3014735311 cites W2610356532 @default.
• W3014735311 cites W2803051237 @default.
• W3014735311 cites W2808754971 @default.
• W3014735311 cites W3001118548 @default.
• W3014735311 cites W3002108456 @default.
• W3014735311 cites W3003322996 @default.
• W3014735311 cites W3003465021 @default.
• W3014735311 cites W3004280078 @default.
• W3014735311 cites W3005212621 @default.
• W3014735311 cites W3005403371 @default.
• W3014735311 cites W3005473082 @default.
• W3014735311 cites W3005905966 @default.
• W3014735311 cites W3008954191 @default.
• W3014735311 cites W4206798761 @default.
• W3014735311 doi "https://doi.org/10.1073/pnas.2004168117" @default.
• W3014735311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7196837" @default.
• W3014735311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32253318" @default.
• W3014735311 hasPublicationYear "2020" @default.
• W3014735311 type Work @default.
• W3014735311 sameAs 3014735311 @default.
• W3014735311 citedByCount "1521" @default.
• W3014735311 countsByYear W30147353112020 @default.
• W3014735311 countsByYear W30147353112021 @default.
• W3014735311 countsByYear W30147353112022 @default.
• W3014735311 countsByYear W30147353112023 @default.
• W3014735311 crossrefType "journal-article" @default.
• W3014735311 hasAuthorship W3014735311A5008957966 @default.
• W3014735311 hasAuthorship W3014735311A5015137228 @default.
• W3014735311 hasAuthorship W3014735311A5018569451 @default.
• W3014735311 hasAuthorship W3014735311A5020780416 @default.

• next